Uttarakhand SLA, Ayush Ministry Stalled Action Against Patanjali: RTI Activist

New Delhi: The Uttarakhand state licensing authority did not register any case against the Ramdev-founded Patanjali Ayurveda company despite the fact that the company violated the SLA’s repeated written missives, ophthalmologist Dr K.V. Babu – who has pursued the case for two years – has said.

A day after the Supreme Court – in no uncertain terms – told off the Uttarakhand government over its inaction when it came to misleading ads released by Patanjali and rejected Patanjali’s apologies, Times of India interviewed Babu.

The doctor and Right to Information activist told the paper that the Union government’s Ayush ministry had received several complaints against Patanjali and would forward these to the Uttarakhand SLA each time. Although Patanjali had claimed in May 2022 to have stopped circulating the misleading ads, in July, it released ads for five drugs, peddling all of them as cures for diabetes, glaucoma, goitre, blood pressure issues and cholesterol.

This violates the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and the Drugs and Cosmetics Act and Rules, 1945, Babu said. Both laws prohibit a medicine from being called a ‘cure’ to some diseases. Conviction under the former can lead to prison sentences of up to a year or more and a fine.

Babu adds that while the SLA would write to Patanjali against the violations, prompted by Babu’s letters, it would stop short of filing cases.

Babu makes it clear that the SLA took up a mild treatment of Patanjali and show caused it under a rule – Rule 170 of the Drugs and Cosmetics Act – which was sub judice. The Ayush ministry, too, concurred that no action could be taken under this rule. However, offences were clearly made out and complaints had been filed under the DMR Act and not the DCA Act, Babu said.

Babu, in the interview, explains a chronology that seems to illustrate that the SLA and Ayush ministry stalled action against Patanjali.

Babu also noted that the company had assumed that the Supreme Court would be comparable in tolerance to the misleading ads as the Ayush ministry and Uttarakhand SLA. Babu said that he himself had been moved to act in the case after seeing that a friend’s mother who had switched to Patanjali medicines for glaucoma grew worse.

Related Posts

  • Pharma
  • September 7, 2024
  • 123 views
Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Coimbatore: A special team of the Coimbatore City Police has arrested a Haryana-based drug distributor on charges of supplying prescription drugs to peddlers in Coimbatore. The police said that Sachin Garg,…

  • Pharma
  • September 7, 2024
  • 100 views
Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Maryland: Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

People with Spinal Injuries are left to fend for themselves in India

People with Spinal Injuries are left to fend for themselves in India

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight